Latest Distributions News

Adavale Resources has reported a standout 19m intercept at 4.0g/t Au well outside the current London-Victoria Mineral Resource Estimate, signalling potential for a significant resource upgrade due in Q3 2026.

Lark Distilling Co. Ltd grew net sales by 15% in FY26, driven by whisky and international expansion, but posted a $40 million loss after goodwill and inventory impairments.

Region Group (ASX: RGN) delivered solid FY26 results with a 3.2% increase in Funds From Operations per security, a 9.8% total security holder return, and a leadership change as Greg Chubb took the helm as CEO.

Vector Limited (NZX:VCT) posted a 55% jump in net profit to $240 million for FY2026, driven by a 20% rise in adjusted EBITDA and a record $544 million capital investment in Auckland’s electricity network.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

Excelsior Capital shareholders have greenlit a $24.3 million capital return set for late August, with the company preparing to delist from the ASX and enter liquidation to finalise remaining asset realisation.

Radiopharm Theranostics is gearing up for a pivotal Phase 3 trial of its brain metastases imaging agent RAD101, following strong Phase 2b results and an upcoming FDA meeting to finalise trial design.

The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.

Steadfast Group's consortium reconfirms $6 per share cash offer, extending exclusivity to 21 August amid final due diligence.

Growthpoint Properties Australia reported a statutory net profit of $90.1 million for FY26, underpinned by record leasing activity and achievement of its Net Zero Target. The group maintained strong portfolio occupancy at 96%, grew funds under management, and provided FY27 guidance reflecting ongoing macroeconomic caution.

L1 Group Limited delivered a standout FY26 with statutory profit up 79% and underlying net profit nearly doubling, driven by merger synergies and strong fund performance.

Lendlease posted a statutory loss of $749 million in FY26, weighed down by impairments in its Capital Release Unit, while its core Investments, Development, and Construction segments delivered solid operating profits and secured significant new projects.